Our Board

  • Ian Tomlinson - Chairman

    Ian Tomlinson - Chairman

    Ian Tomlinson has over 25 years of experience in the lifesciences sector from academic research to biotech startup to big pharma. He founded Domantis Limited with Sir Gregory Winter, which was acquired by GSK for $454million. He then served as Senior VP, Head of Worldwide Business... read more


  • Dr Sally Ann Forsyth: Chief Executive Officer

    Dr Sally Ann Forsyth: Chief Executive Officer

    Dr Sally Ann became CEO of Stevenage Bioscience Catalyst (SBC) on 5th March 2018 with the aim of developing SBC to its full potential as a world class science, innovation and business cluster. Before coming to SBC, Sally Ann was CEO of Norwich Research Park, a life science cluster of world... read more


  • Dave Allen - GSK Representative

    Dave Allen - GSK Representative

    Dave Allen is the head of the Respiratory Therapy Area at GSK and is responsible for the identification of novel differentiated medicines and their progression to registration and launch. He leads a group of over 200 scientists and clinicians who exploit scientific innovations that have the... read more


  • Iain Ward - Wellcome representative

    Iain Ward - Wellcome representative

    Iain joined as Senior Legal Counsel in November 2015 and is now Associate General Counsel (Innovations) coming directly from Consort Medical plc where he was Group General Counsel and Company Secretary. Previously he was Head of legal for Europe, Middle East and Africa for Shire plc from 2006 to... read more


  • Dr Veronique A Bouchet Independent Director

    Dr Veronique A Bouchet Independent Director

    Veronique Bouchet has over 25 years' experience in the healthcare industry, and is the Founder Director of Novudel Associates, a life sciences consulting and coaching company. Prior to this post she was Director of Corporate Strategy and Head of VC Relations at AstraZeneca, where she was... read more




Funding Partners: